Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.3760
+0.0275 (7.89%)
Aug 14, 2026, 1:18 PM EDT - Market open
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $5.53 million as of August 14, 2026. Its market cap has decreased by -13.43% in one year.
Market Cap
5.53M
Enterprise Value
5.05M
1-Year Change
-13.43%
Ranking
Category
Stock Price
$0.38
ChartMarket Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $5.53M, a decrease of -99.99%. That is a compound annual growth rate of -66.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 5.53M | 65.34% |
| Dec 31, 2025 | 3.34M | -68.54% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaCyte Biotech | 5.90M |
| BioAtla | 5.73M |
| BioRestorative Therapies | 5.61M |
| Enveric Biosciences | 5.56M |
| Pulmatrix | 5.51M |
| Cadrenal Therapeutics | 5.33M |
| GeoVax Labs | 5.29M |
| Ernexa Therapeutics | 5.02M |